163 related articles for article (PubMed ID: 35095075)
1. Prognostic Implications of Mitral Valve Inflow Pattern Overlap during Ivabradine Therapy.
Imamura T; Hori M; Narang N; Besser S; Kinugawa K
Int Heart J; 2022; 63(1):43-48. PubMed ID: 35095075
[TBL] [Abstract][Full Text] [Related]
2. Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure.
Tondi L; Fragasso G; Spoladore R; Pinto G; Gemma M; Slavich M; Godino C; Salerno A; Montanaro C; Margonato A
J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):351-356. PubMed ID: 29762337
[TBL] [Abstract][Full Text] [Related]
3. Implications of Heart Rate in Patients with Left Ventricular Assist Devices.
Imamura T; Kinugawa K; Narang N; Nishida H; Pinney S; Jeevanandam V; Ota T
Int Heart J; 2022; 63(1):56-61. PubMed ID: 35095077
[TBL] [Abstract][Full Text] [Related]
4. Effect of Reducing Heart Rate on Outcomes in Patients With Reduced Ejection Fraction.
Lan WR; Lin SI; Liao FC; Chang HY; Tsai CT; Wu YJ; Liu PY; Chen CH; Lee YH
Am J Cardiol; 2021 Jul; 150():77-81. PubMed ID: 34006371
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of heart failure treated with digoxin or with ivabradine: A cohort study in the community.
Guzman M; Gomez R; Romero SP; Aranda R; Andrey JL; Pedrosa MJ; Egido J; Gomez F
Int J Clin Pract; 2018 Nov; 72(11):e13217. PubMed ID: 30248211
[TBL] [Abstract][Full Text] [Related]
6. Chronotropic Assessment in Patients with Constrictive Pericarditis.
Imamura T; Narang N; Besser S; Kinugawa K
Int Heart J; 2021 Jul; 62(4):811-815. PubMed ID: 34234074
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.
Bouabdallaoui N; O'Meara E; Bernier V; Komajda M; Swedberg K; Tavazzi L; Borer JS; Bohm M; Ford I; Tardif JC
ESC Heart Fail; 2019 Dec; 6(6):1199-1207. PubMed ID: 31591826
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure - J-SHIFT Study.
Tsutsui H; Momomura SI; Yamashina A; Shimokawa H; Kihara Y; Saito Y; Hagiwara N; Ito H; Yano M; Yamamoto K; Ako J; Inomata T; Sakata Y; Tanaka T; Kawasaki Y;
Circ J; 2019 Sep; 83(10):2049-2060. PubMed ID: 31391387
[TBL] [Abstract][Full Text] [Related]
9. Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction.
Böhm M; Abdin A; Slawik J; Mahfoud F; Borer J; Ford I; Swedberg K; Tavazzi L; Batailler C; Komajda M
Eur J Heart Fail; 2023 Aug; 25(8):1429-1435. PubMed ID: 37092340
[TBL] [Abstract][Full Text] [Related]
10. Effect of ivabradine in heart failure: a meta-analysis of heart failure patients with reduced versus preserved ejection fraction.
Tóth N; Soós A; Váradi A; Hegyi P; Tinusz B; Vágvölgyi A; Orosz A; Solymár M; Polyák A; Varró A; Farkas AS; Nagy N
Can J Physiol Pharmacol; 2021 Nov; 99(11):1159-1174. PubMed ID: 34636643
[TBL] [Abstract][Full Text] [Related]
11. The association between ivabradine and adverse cardiovascular events in acute decompensated HFrEF patients.
Liao CT; Huang JL; Liang HW; Chung FP; Lee YH; Lin PL; Chiou WR; Lin WY; Hsu CY; Chang HY
ESC Heart Fail; 2021 Oct; 8(5):4199-4210. PubMed ID: 34327853
[TBL] [Abstract][Full Text] [Related]
12. How to Estimate the Optimal Heart Rate in Patients with Heart Failure with Preserved Ejection Fraction.
Izumida T; Imamura T; Fukui T; Koi T; Ueno Y; Hori M; Nakagaito M; Tanaka S; Kataoka N; Ushijima R; Nakamura M; Sobajima M; Fukuda N; Ueno H; Kinugawa K
Int Heart J; 2021 Jul; 62(4):816-820. PubMed ID: 34276013
[TBL] [Abstract][Full Text] [Related]
13. Doppler Echocardiography-Guided Heart Rate Modulation Therapy Using Ivabradine in a Patient with Systolic Heart Failure.
Imamura T; Kinugawa K
Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208489
[TBL] [Abstract][Full Text] [Related]
14. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.
Komajda M; Isnard R; Cohen-Solal A; Metra M; Pieske B; Ponikowski P; Voors AA; Dominjon F; Henon-Goburdhun C; Pannaux M; Böhm M;
Eur J Heart Fail; 2017 Nov; 19(11):1495-1503. PubMed ID: 28462519
[TBL] [Abstract][Full Text] [Related]
15. Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study.
Böhm M; Borer J; Ford I; Gonzalez-Juanatey JR; Komajda M; Lopez-Sendon J; Reil JC; Swedberg K; Tavazzi L
Clin Res Cardiol; 2013 Jan; 102(1):11-22. PubMed ID: 22575988
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety analysis of ivabradine hydrochloride treatment of Chinese patients with chronic heart failure: subgroup analysis of Chinese patients in the SHIFT study].
Hu DY; Huang DJ; Yuan ZY; Zhao RP; Yan XW; Wang MH;
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):190-197. PubMed ID: 28316174
[No Abstract] [Full Text] [Related]
17. The prognostic importance of a history of hypertension in patients with symptomatic heart failure is substantially worsened by a short mitral inflow deceleration time.
Andersson C; Gislason GH; Weeke P; Kjaergaard J; Hassager C; Akkan D; Møller JE; Køber L; Torp-Pedersen C;
BMC Cardiovasc Disord; 2012 Apr; 12():30. PubMed ID: 22533520
[TBL] [Abstract][Full Text] [Related]
18. The Importance of Heart Rate in Heart Failure and Reduced Ejection Fraction.
Prasun MA; Albert NM
J Cardiovasc Nurs; 2018; 33(5):453-459. PubMed ID: 29621054
[TBL] [Abstract][Full Text] [Related]
19. Ivabradine for treatment of heart failure.
Bocchi EA; Salemi VMC
Expert Opin Drug Saf; 2019 May; 18(5):393-402. PubMed ID: 31074301
[TBL] [Abstract][Full Text] [Related]
20. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.
Böhm M; Swedberg K; Komajda M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L;
Lancet; 2010 Sep; 376(9744):886-94. PubMed ID: 20801495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
